Welcome to our dedicated page for Innoviz Technologies SEC filings (Ticker: INVZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Innoviz Technologies Ltd. (NASDAQ: INVZ), a LiDAR technology company and Tier-1 supplier to automotive manufacturers. As a foreign private issuer, Innoviz files annual reports on Form 20-F and current reports on Form 6-K, which together offer detailed insight into its operations, financial condition, and material developments.
Recent Form 6-K filings referenced in company disclosures include interim unaudited consolidated financial statements, operating and financial reviews, and press releases covering quarterly results, commercial updates, and compliance matters. For example, Innoviz has furnished 6-Ks that attach financial statements for periods ended June 30 and September 30, 2025, operating and financial review documents, and earnings press releases. Other 6-Ks relate to its annual general meeting of shareholders, proxy materials, and notices regarding the meeting agenda and voting outcomes.
Filings also document governance decisions, such as the re-election of directors, readoption of a compensation policy for executive officers and directors, approval of certain compensation for the chief executive officer, and re-appointment of the company’s independent auditors. Additional reports include disclosures about regaining compliance with Nasdaq’s minimum bid price requirement and the incorporation by reference of specific exhibits into registration statements on Form F-3 and Form S-8.
On Stock Titan, Innoviz’s SEC filings are updated in near real time as they are posted to EDGAR. Users can review Forms 20-F, 6-K, and related exhibits, and use AI-powered summaries to understand key points from lengthy financial and legal documents. The filings page also offers a path to monitor items such as capital markets activity and other regulatory disclosures that may be relevant to INVZ shareholders and analysts.
Innoviz Technologies Ltd. reported that Nasdaq has notified the company it no longer meets the exchange’s $1.00 minimum bid price requirement, after its ordinary shares closed below this level for 30 consecutive business days. The shares remain listed on the Nasdaq Capital Market under the symbol INVZ with no immediate impact.
Innoviz has a 180-day grace period, until September 21, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive trading days. If other listing standards are met, Innoviz may qualify for an additional 180-day period and plans to monitor its share price and consider options to restore compliance.
Innoviz Technologies Ltd. director Dan Michael Falk filed an initial ownership report showing beneficial ownership of 234,329 Ordinary Shares. This total includes 107,083 Ordinary Shares issuable upon vesting of restricted share units granted on May 13, 2025, which are scheduled to vest on April 5, 2026.
Innoviz Technologies Ltd. Chief R&D Officer Avishay Ben Moscovici filed an initial ownership report showing his equity position in the company. He directly holds 330,665 ordinary shares, along with multiple share option grants over ordinary shares with exercise prices ranging from $0.5695 to $11.50 and expirations between 2027 and 2032.
The filing also notes 172,296 ordinary shares issuable upon vesting of restricted share units (RSUs), granted between 2022 and 2025, with quarterly vesting schedules running through 2029, subject to his continued service. Each RSU represents a contingent right to receive one ordinary share.
Innoviz Technologies Ltd. executive Ido Luski has reported his initial ownership position as Chief Operating Officer. The Form 3 shows direct ownership of 329,013 ordinary shares, plus multiple share option grants over ordinary shares with exercise prices ranging from $0.5695 to $11.5000 and expirations between 2028 and 2032.
A footnote also indicates 198,864 ordinary shares are issuable upon vesting of restricted share units, with various grants from 2022 through 2025 scheduled to vest quarterly through 2029, subject to Luski remaining a service provider. The filing reflects existing equity awards rather than new market purchases or sales.
Innoviz Technologies Ltd. director and Chief Executive Officer Omer David Keilaf reported his initial ownership on Form 3. He directly holds 4,228,950 ordinary shares, which include 1,143,106 shares issuable upon vesting of restricted share units granted between 2022 and 2025 on various quarterly schedules.
He also holds multiple option grants over Innoviz ordinary shares, including 1,020,444 options at an exercise price of $11.50 expiring in 2028 and additional tranches at lower exercise prices expiring through 2032, plus 40,000 public warrants at $11.50. In addition, he holds 6,256,265 performance share units that may convert into ordinary shares if share-price targets between $2.00 and $5.50 are met and service conditions are satisfied.
Innoviz Technologies Ltd. Chief Business Officer Hofstetter Elad Ben filed an initial statement of beneficial ownership, detailing his equity position in the company. He holds 232,144 Ordinary Shares directly and multiple option grants over additional ordinary shares at exercise prices ranging from $0.5695 to $8.5000, with expirations between 2028 and 2032.
The filing also notes 143,906 Ordinary Shares issuable upon vesting of restricted share units, granted between August 2022 and November 2025, with vesting schedules that generally run quarterly through 2029 or 2028. Vesting and unvested options are conditioned on Hofstetter continuing as a service provider to Innoviz on each vesting date. This Form 3 does not report any new purchases or sales, only existing holdings and equity awards.
Innoviz Technologies Ltd. Chief Financial Officer Cegla Eldar Mordechay reports his equity holdings in the company. He directly holds 464,053 Ordinary Shares. In addition, he has share options over multiple blocks of Ordinary Shares, with exercise prices ranging from 0.0569 to 11.5000 and expiration dates between 2027-08-10 and 2032-08-05. The disclosure also notes 189,854 Ordinary Shares issuable upon vesting of restricted share units granted between 2022 and 2025, vesting in quarterly installments through 2029, subject to his continued service. This Form 3 reflects existing beneficial ownership and awards rather than new market transactions.
Innoviz Technologies Ltd. director Jacoby Stefan filed an initial ownership report showing beneficial ownership of 181,326 ordinary shares. This amount includes 107,083 ordinary shares issuable upon vesting of restricted share units granted on May 13, 2025, which are scheduled to vest on April 5, 2026.
Innoviz Technologies Ltd. director Maor Shenaar Ronit filed an initial Form 3 reporting beneficial ownership of 234,329 ordinary shares. This total includes 107,083 ordinary shares issuable upon vesting of restricted share units granted on May 13, 2025, which vest on April 5, 2026.
Innoviz Technologies Ltd. director Orit Stav has reported initial ownership of 234,329 ordinary shares of the company. This Form 3 filing outlines the director’s current stake rather than any new share purchase or sale.
The reported holdings include 107,083 ordinary shares that are issuable upon vesting of restricted share units granted on May 13, 2025, which vest on April 5, 2026. Each RSU represents a contingent right to receive one ordinary share with no exercise price payable.